Fiduciary Alliance LLC higher its place in stocks of Johnson & Johnson (NYSE:JNJ – Loose File) through 4.0% within the 2d quarter, in keeping with its most up-to-date disclosure with the SEC. The institutional investor owned 80,491 stocks of the corporate’s inventory after buying an extra 3,118 stocks all the way through the quarter. Johnson & Johnson makes up roughly 2.9% of Fiduciary Alliance LLC’s funding portfolio, making the inventory its ninth greatest place. Fiduciary Alliance LLC’s holdings in Johnson & Johnson have been value $13,323,000 on the finish of the latest quarter.

A number of different massive buyers have additionally lately made adjustments to their positions within the corporate. Marietta Wealth Control LLC grew its holdings in Johnson & Johnson through 1.8% within the 2d quarter. Marietta Wealth Control LLC now owns 29,133 stocks of the corporate’s inventory valued at $4,822,000 after purchasing an extra 524 stocks within the final quarter. Northwest Financial institution & Consider Co bought a brand new place in stocks of Johnson & Johnson within the 2d quarter valued at $235,000. Built-in Funding Experts LLC bought a brand new place in stocks of Johnson & Johnson within the 2d quarter valued at $856,000. Catalyst Non-public Wealth LLC lifted its stake in stocks of Johnson & Johnson through 7.2% within the 2d quarter. Catalyst Non-public Wealth LLC now owns 1,698 stocks of the corporate’s inventory valued at $281,000 after buying an extra 114 stocks all the way through the final quarter. In the end, KFA Non-public Wealth Staff LLC lifted its stake in stocks of Johnson & Johnson through 4.2% within the 2d quarter. KFA Non-public Wealth Staff LLC now owns 6,289 stocks of the corporate’s inventory valued at $1,041,000 after buying an extra 252 stocks all the way through the final quarter. 68.40% of the inventory is these days owned through hedge price range and different institutional buyers.

Insiders Position Their Bets

In different Johnson & Johnson information, insider William Hait bought 14,698 stocks of the company’s inventory in a transaction on Wednesday, July twenty sixth. The inventory used to be bought at a median value of $172.00, for a complete transaction of $2,528,056.00. Following the finishing touch of the transaction, the insider now owns 87,747 stocks of the corporate’s inventory, valued at $15,092,484. The transaction used to be disclosed in a report filed with the Securities & Alternate Fee, which is on the market via this hyperlink. In different Johnson & Johnson information, VP Peter Fasolo bought 20,000 stocks of the industry’s inventory in a transaction dated Tuesday, July twenty fifth. The inventory used to be bought at a median value of $170.32, for a complete transaction of $3,406,400.00. Following the finishing touch of the sale, the vp now owns 102,696 stocks of the corporate’s inventory, valued at $17,491,182.72. The transaction used to be disclosed in a report filed with the SEC, which is to be had via this link. Additionally, insider William Hait bought 14,698 stocks of the industry’s inventory in a transaction dated Wednesday, July twenty sixth. The stocks have been bought at a median value of $172.00, for a complete price of $2,528,056.00. Following the sale, the insider now immediately owns 87,747 stocks of the corporate’s inventory, valued at roughly $15,092,484. The disclosure for this sale will also be discovered right here. 0.20% of the inventory is these days owned through corporate insiders.

Johnson & Johnson Inventory Down 0.7 %

JNJ opened at $155.75 on Monday. The industry has a 50 day easy shifting moderate of $165.97 and a 200-day easy shifting moderate of $162.29. The inventory has a marketplace capitalization of $404.79 billion, a P/E ratio of 31.53, a P/E/G ratio of three.15 and a beta of 0.55. Johnson & Johnson has a 12 month low of $150.11 and a 12 month prime of $181.04. The corporate has a debt-to-equity ratio of 0.44, a present ratio of one.12 and a handy guide a rough ratio of 0.88.

Johnson & Johnson (NYSE:JNJ – Get Loose File) final issued its quarterly profits knowledge on Thursday, July twentieth. The corporate reported $2.80 profits in keeping with percentage (EPS) for the quarter, topping the consensus estimate of $2.62 through $0.18. The company had earnings of $25.53 billion all the way through the quarter, in comparison to analysts’ expectancies of $24.63 billion. Johnson & Johnson had a go back on fairness of 36.72% and a web margin of 13.35%. Johnson & Johnson’s earnings used to be up 6.3% on a year-over-year foundation. All through the similar duration within the earlier 12 months, the company posted $2.59 profits in keeping with percentage. On moderate, equities analysts await that Johnson & Johnson will put up 10.02 profits in keeping with percentage for the present fiscal 12 months.

Johnson & Johnson Dividend Announcement

The industry additionally lately declared a quarterly dividend, which used to be paid on Thursday, September seventh. Shareholders of report on Monday, August twenty eighth got a dividend of $1.19 in keeping with percentage. This represents a $4.76 annualized dividend and a yield of three.06%. The ex-dividend date used to be Friday, August twenty fifth. Johnson & Johnson’s payout ratio is 96.36%.

Analysts Set New Value Objectives

A number of equities analysts lately issued studies at the corporate. Cantor Fitzgerald reissued an “obese” ranking and set a $215.00 goal value on stocks of Johnson & Johnson in a analysis notice on Monday, September 18th. Raymond James decreased their value goal on Johnson & Johnson from $184.00 to $179.00 and set an “outperform” ranking at the inventory in a analysis record on Tuesday, September fifth. Barclays decreased their value goal on Johnson & Johnson from $175.00 to $158.00 and set an “equivalent weight” ranking at the inventory in a analysis record on Friday, September eighth. Morgan Stanley dropped their value purpose on Johnson & Johnson from $187.00 to $172.00 and set an “equivalent weight” ranking at the inventory in a record on Thursday, August thirty first. In the end, JPMorgan Chase & Co. higher their value purpose on Johnson & Johnson from $175.00 to $180.00 and gave the corporate a “impartial” ranking in a record on Friday, July twenty first. 9 analysts have rated the inventory with a grasp ranking, 5 have issued a purchase ranking and one has issued a robust purchase ranking to the inventory. In line with knowledge from MarketBeat.com, Johnson & Johnson these days has a median ranking of “Grasp” and a median goal value of $170.65.

Learn Our Newest Inventory Research on JNJ

Johnson & Johnson Profile

(Loose File)

Johnson & Johnson, at the side of its subsidiaries, researches, develops, manufactures, and sells quite a lot of merchandise within the healthcare box international. The corporate’s Client Well being section supplies pores and skin well being/attractiveness merchandise underneath the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise underneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise underneath the LISTERINE emblem; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and allergic reaction merchandise; BENADRYL and ZYRTEC allergic reaction merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disorder merchandise.

Featured Articles

Obtain Information & Rankings for Johnson & Johnson Day-to-day – Input your electronic mail cope with underneath to obtain a concise day-to-day abstract of the newest information and analysts’ scores for Johnson & Johnson and similar firms with MarketBeat.com’s FREE day-to-day electronic mail publication.